调肝法治疗桥本氏甲状腺炎临床研究  

Clinical Study on the Treatment of Hashimoto′s Thyroiditis by Regulating the Liver

作　　者：戴琴 徐骁 DAI Qin;XU Xiao(Fengxian District Hospital of TCM of Shanghai,Shanghai,China,201400)

机构地区：[1]上海市奉贤区中医医院,上海201400

出　　处：《河南中医》2020年第6期882-885,共4页Henan Traditional Chinese Medicine

摘　　要：目的:观察调肝法治疗桥本氏甲状腺炎的临床疗效。方法:选取本院治疗的桥本氏甲状腺炎患者40例,随机分为治疗组和对照组,每组20例。对照组给予硒酵母片口服治疗,治疗组给予调肝法治疗。结果:治疗3个月后,治疗组症状体征积分及甲状腺过氧化物酶抗体、甲状腺球蛋白抗体水平低于对照组,差异有统计学意义(P<0.05);治疗3个月后,两组治疗后甲状腺激素水平较治疗前无明显变化,差异无统计学意义(P>0.05),治疗组与对照组组间比较,差异无统计学意义(P>0.05);治疗组有效率为85.00%,对照组有效率为60.00%,治疗组高于对照组,差异有统计学意义(P<0.05)。结论:调肝法治疗桥本氏甲状腺炎,可改善患者甲状腺激素水平和甲状腺过氧化物酶抗体、甲状腺球蛋白抗体水平。Objective:To observe the clinical curative effect of liver-regulating method on hashimoto′s thyroiditis(HT).Methods:A total of 40 patients with HT treated in our hospital were randomly divided into the treatment group and the control group,with 20 cases in each group.The control group was given Selenium Yeast Tablet for oral administration,and the treatment group was given liver-regulating therapy.Results:After 3 months of treatment,the scores of symptoms and signs,the levels of thyroperoxidase antibody and thyroglobulin antibody in the treatment group were lower than those in the control group,and all the differences were statistically significant(P<0.05).After 3 months of treatment,there was no significant change in thyroid hormone level in the two groups(P>0.05),and there was no significant difference between the treatment group and the control group(P>0.05).The effective rate was 85.00%in the treatment group and 60.00%in the control group.The difference was statistically significant(P<0.05).Conclusion:Liver-regulating therapy has a remarkable clinical curative effect on HT,can improve the levels of thyroid hormone,thyroid peroxidase antibody and thyroglobulin antibody.

关 键 词：桥本氏甲状腺炎 调肝法 甲状腺激素 甲状腺过氧化物酶抗体 甲状腺球蛋白抗体 

分 类 号：R259.814[医药卫生—中西医结合]